{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:41:46Z","timestamp":1790710906615,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04031-8","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T09:02:52Z","timestamp":1755421372000},"page":"527-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploratory evaluation of CA 15-3\u2009\u00d7\u2009NLR score for predicting pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-1816","authenticated-orcid":false,"given":"Emine Bihter","family":"Eniseler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-5395","authenticated-orcid":false,"given":"Bartu","family":"\u00c7etin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9317-942X","authenticated-orcid":false,"given":"Ferhat","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-7574","authenticated-orcid":false,"given":"Atike P\u0131nar","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-593X","authenticated-orcid":false,"given":"Mustafa","family":"\u015eahbazlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"issue":"6797","key":"4031_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352. https:\/\/doi.org\/10.1038\/35021093.","journal-title":"Nature"},{"issue":"9938","key":"4031_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(13)62422-8.","journal-title":"Lancet"},{"issue":"15","key":"4031_CR3","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796\u2013804. https:\/\/doi.org\/10.1200\/JCO.2011.38.8595.","journal-title":"J Clin Oncol"},{"issue":"10","key":"4031_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1200\/JCO.2015.63.1010","volume":"35","author":"WF Symmans","year":"2017","unstructured":"Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, et al. Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype. J Clin Oncol. 2017;35(10):1049\u201360. https:\/\/doi.org\/10.1200\/JCO.2015.63.1010.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4031_CR5","doi-asserted-by":"publisher","first-page":"znae132","DOI":"10.1093\/bjs\/znae132","volume":"111","author":"GP Dowling","year":"2024","unstructured":"Dowling GP, Daly GR, Hegarty A, Hembrecht S, Bracken A, Toomey S, et al. Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis. Br J Surg. 2024;111(5):znae132. https:\/\/doi.org\/10.1093\/bjs\/znae132.","journal-title":"Br J Surg"},{"issue":"1","key":"4031_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","volume":"19","author":"JL Ethier","year":"2017","unstructured":"Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19(1):2. https:\/\/doi.org\/10.1186\/s13058-016-0794-1.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4031_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/bjc.2015.183","volume":"113","author":"CH Koh","year":"2015","unstructured":"Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, et al. Utility of pre-treatment neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer. 2015;113(1):150\u20138. https:\/\/doi.org\/10.1038\/bjc.2015.183.","journal-title":"Br J Cancer"},{"issue":"3","key":"4031_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1373\/clinchem.2005.059832","volume":"52","author":"MJ Duffy","year":"2006","unstructured":"Duffy MJ. Serum tumor markers in breast cancer: are they of clinical value? Clin Chem. 2006;52(3):345\u201351. https:\/\/doi.org\/10.1373\/clinchem.2005.059832.","journal-title":"Clin Chem"},{"issue":"3","key":"4031_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3892\/ol.2024.14562","volume":"28","author":"B Alshamsan","year":"2024","unstructured":"Alshamsan B, Elshenawy MA, Aseafan M, Fahmy N, Badran A, Elhassan T, et al. Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer. Oncol Lett. 2024;28(3):429. https:\/\/doi.org\/10.3892\/ol.2024.14562.","journal-title":"Oncol Lett"},{"issue":"9","key":"4031_CR10","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1002\/cam4.2281","volume":"8","author":"W Guo","year":"2019","unstructured":"Guo W, Lu X, Liu Q, Zhang T, Li P, Qiao W, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: an updated meta-analysis of 17079 individuals. Cancer Med. 2019;8(9):4135\u201348. https:\/\/doi.org\/10.1002\/cam4.2281.","journal-title":"Cancer Med"},{"key":"4031_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12885-016-2352-8","volume":"16","author":"Y Chen","year":"2016","unstructured":"Chen Y, Chen K, Xiao X, Nie Y, Qu S, Gong C, et al. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study. BMC Cancer. 2016;16:320. https:\/\/doi.org\/10.1186\/s12885-016-2352-8.","journal-title":"BMC Cancer"},{"issue":"4","key":"4031_CR12","doi-asserted-by":"publisher","first-page":"155932581988981","DOI":"10.1177\/1559325819889814","volume":"17","author":"QP Zhou","year":"2019","unstructured":"Zhou QP, Li XJ. C-Reactive protein to albumin ratio in colorectal cancer: a meta-analysis of prognostic value. Dose Response. 2019;17(4):1559325819889814. https:\/\/doi.org\/10.1177\/1559325819889814.","journal-title":"Dose Response"},{"issue":"4","key":"4031_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4274\/imj.galenos.2024.96266","volume":"25","author":"\u00c7 Y\u0131ld\u0131r\u0131m","year":"2024","unstructured":"Y\u0131ld\u0131r\u0131m \u00c7, Teker F, \u00d6kten \u0130N, G\u00fclt\u00fcrk \u0130, Aytekin A, Aytekin A. Relationship of neoadjuvant chemotherapy efficacy with histopathologic molecular subtypes in breast cancer patients. Istanb Med J. 2024;25(4):274\u201380. https:\/\/doi.org\/10.4274\/imj.galenos.2024.96266.","journal-title":"Istanb Med J"},{"issue":"15","key":"4031_CR14","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/cncr.24396","volume":"115","author":"C Liebig","year":"2009","unstructured":"Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115(15):3379\u201391. https:\/\/doi.org\/10.1002\/cncr.24396.","journal-title":"Cancer"},{"issue":"1","key":"4031_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04031-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04031-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04031-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:46:48Z","timestamp":1769694408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04031-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4031"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04031-8","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Manisa Celal Bayar University (Decision No: 20.47.486, dated 26.03.2025) and conducted in accordance with the Declaration of Helsinki and its later amendments. Due to the retrospective and anonymized design of the study, the requirement for informed consent was waived in accordance with institutional and journal policies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}